Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tibotec Pharmaceuticals, Ireland

Clinical trials sponsored by Tibotec Pharmaceuticals, Ireland, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Pharmaceutical company focused on infectious diseases, a subsidiary of Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for Drug-Resistant HIV: early access to TMC125

Disease control APPROVED_FOR_MARKETING

This study provides early access to the experimental drug TMC125 (etravirine) for HIV-1 patients who have failed multiple treatments and have few options left. Participants take TMC125 along with other antiretroviral drugs chosen by their doctor. The study tracks safety and how w…

Sponsor: Tibotec Pharmaceuticals, Ireland • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC